This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Görtz, B. Articles by Komminoth, P. Search for Related Content PubMed PubMed Citation Articles by Görtz, B. Articles by Komminoth, P.

(American Journal of Pathology. 1999;154:429-436.)
© 1999 American Society for Investigative Pathology

Regular Articles

Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms

Birgit Görtz* , Jürgen Roth , Akiko Krähenmann* , Ronald R. de Krijger , Seraina Muletta-Feurer* , Katrin Rütimann* , Parvin Saremaslani* , Ernst J. M. Speel* , Philipp U. Heitz* and Paul Komminoth*

From the Department of Pathology* and the Division of Cell and Molecular Pathology, University of Zurich, Zurich, Switzerland, and the Department of Pathology, Erasmus University of Rotterdam, Rotterdam, The Netherlands

Endocrine pancreatic tumors (EPT) and neuroendocrine tumors (NET) occur sporadically and rarely in association with multiple endocrine neoplasia type 1 (MEN1). We analyzed the frequency of allelic deletions and mutations of the recently identified MEN1 gene in 53 sporadic tumors including 30 EPT and 23 NET (carcinoids) of different locations and types. Allelic deletion of the MEN1 locus was identified in 18/49 (36.7%) tumors (13/30, 43.3% in EPT and 5/19, 26.3% in NET) and mutations of the MEN1 gene were present in 8/52 (15.3%) tumors (4/30 (13.3%) EPT and 4/22 (18.1%) NET). The somatic mutations were clustered in the 5' region of the coding sequence and most frequently encompassed missense mutations. All tumors with mutations exhibited a loss of the other allele and a wild-type sequence of the MEN1 gene in nontumorous DNA. In one additional patient with a NET of the lung and no clinical signs or history of MEN1, a 5178–9GA splice donor site mutation in intron 4 was identified in both the tumor and blood DNA, indicating the presence of a thus far unknown MEN1 syndrome. In most tumor groups the frequency of allelic deletions at 11q13 was 2 to 3 times higher than the frequency of identified MEN1 gene mutations. Some tumor types, including rare forms of EPT and NET of the duodenum and small intestine, exhibited mutations more frequently than other types. Furthermore, somatic mutations were not restricted to foregut tumors but were also detectable in a midgut tumor (15.2% versus 16.6%). Our data indicate that somatic MEN1 gene mutations contribute to a subset of sporadic EPT and NET, including midgut tumors. Because the frequency of mutations varies significantly among the investigated tumor subgroups and allelic deletions are 2 to 3 times more frequently observed, factors other than MEN1 gene inactivation, including other tumor-suppressor genes on 11q13, may also be involved in the tumorigenesis of these neoplasms.

This article has been cited by other articles:

				Y. Nagano, D. H. Kim, L. Zhang, J. A White, J. C Yao, S. R Hamilton, and A. Rashid Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis Endocr. Relat. Cancer, June 1, 2007; 14(2): 483 - 492. [Abstract] [Full Text] [PDF]

				Y M H Jonkers, S M H Claessen, A Perren, S Schmid, P Komminoth, A A Verhofstad, L J Hofland, R R de Krijger, P J Slootweg, F C S Ramaekers, et al. Chromosomal instability predicts metastatic disease in patients with insulinomas Endocr. Relat. Cancer, June 1, 2005; 12(2): 435 - 447. [Abstract] [Full Text] [PDF]

				D. Furlan, R. Cerutti, S. Uccella, S. La Rosa, E. Rigoli, A. Genasetti, and C. Capella Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancreatic Tract Clin. Cancer Res., February 1, 2004; 10(3): 947 - 957. [Abstract] [Full Text] [PDF]

				J. J. O. Turner, P. D. Leotlela, A. A. J. Pannett, S. A. Forbes, J. H. D. Bassett, B. Harding, P. T. Christie, D. Bowen-Jones, S. Ellard, A. Hattersley, et al. Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2688 - 2693. [Abstract] [Full Text] [PDF]

				S. S. Guo and M. P. Sawicki Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1 Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664. [Abstract] [Full Text] [PDF]

				N. Lubomierski, M. Kersting, T. Bert, K. Muench, U. Wulbrand, M. Schuermann, D. Bartsch, and B. Simon Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors Cancer Res., August 1, 2001; 61(15): 5905 - 5910. [Abstract] [Full Text] [PDF]

				E. J. M. Speel, A. F. Scheidweiler, J. Zhao, C. Matter, P. Saremaslani, J. Roth, P. U. Heitz, and P. Komminoth Genetic Evidence for Early Divergence of Small Functioning and Nonfunctioning Endocrine Pancreatic Tumors: Gain of 9Q34 Is an Early Event in Insulinomas Cancer Res., July 1, 2001; 61(13): 5186 - 5192. [Abstract] [Full Text] [PDF]

				A. Barghorn, E. J. M. Speel, B. Farspour, P. Saremaslani, S. Schmid, A. Perren, J. Roth, P. U. Heitz, and P. Komminoth Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors Am. J. Pathol., June 1, 2001; 158(6): 1903 - 1911. [Abstract] [Full Text] [PDF]

				D. Desai, L. A. McPherson, J. P. T. Higgins, and R. J. Weigel Genetic Analysis of a Papillary Thyroid Carcinoma in a Patient with MEN1 Ann. Surg. Oncol., May 1, 2001; 8(4): 342 - 346. [Abstract] [Full Text] [PDF]

				H Tonnies, M R Toliat, C Ramel, U F Pape, H Neitzel, W Berger, and B Wiedenmann Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation Gut, April 1, 2001; 48(4): 536 - 541. [Abstract] [Full Text] [PDF]

				J. Zhao, R. R. de Krijger, D. Meier, E.-J. M. Speel, P. Saremaslani, S. Muletta-Feurer, C. Matter, J. Roth, P. U. Heitz, and P. Komminoth Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids) : Marked Differences Indicating Diversity in Molecular Pathogenesis Am. J. Pathol., November 1, 2000; 157(5): 1431 - 1438. [Abstract] [Full Text] [PDF]

				F. Yu, R. T. Jensen, I. A. Lubensky, E. H. Mahlamaki, Y.-L. Zheng, A. M. Herr, and L. J. Ferrin Survey of Genetic Alterations in Gastrinomas Cancer Res., October 1, 2000; 60(19): 5536 - 5542. [Abstract] [Full Text]

				A. Perren, P. Komminoth, P. Saremaslani, C. Matter, S. Feurer, J. A. Lees, P. U. Heitz, and C. Eng Mutation and Expression Analyses Reveal Differential Subcellular Compartmentalization of PTEN in Endocrine Pancreatic Tumors Compared to Normal Islet Cells Am. J. Pathol., October 1, 2000; 157(4): 1097 - 1103. [Abstract] [Full Text] [PDF]

				E. J. M. Speel, J. Richter, H. Moch, C. Egenter, P. Saremaslani, K. Rutimann, J. Zhao, A. Barghorn, J. Roth, P. U. Heitz, et al. Genetic Differences in Endocrine Pancreatic Tumor Subtypes Detected by Comparative Genomic Hybridization Am. J. Pathol., December 1, 1999; 155(6): 1787 - 1794. [Abstract] [Full Text] [PDF]

				M. Volante, M. Papotti, J. Roth, P. Saremaslani, E. J. M. Speel, R. V. Lloyd, J. A. Carney, P. U. Heitz, G. Bussolati, and P. Komminoth Mixed Medullary-Follicular Thyroid Carcinoma : Molecular Evidence for a Dual Origin of Tumor Components Am. J. Pathol., November 1, 1999; 155(5): 1499 - 1509. [Abstract] [Full Text] [PDF]